Composition for Promoting Production of Immunostimulatory Factor
US-2019290674-A1 · Sep 26, 2019 · US
Nucleic acids or derivatives thereof (A23L33/145 takes precedence)
Nucleic acids or derivatives thereof (A23L33/145 takes precedence) · Cooperative Patent Classification (CPC)
Agriculture, food, personal care, health, and life sciences.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | A23L33/13 |
| Official title | Nucleic acids or derivatives thereof (A23L33/145 takes precedence) |
| Display label | Nucleic acids or derivatives thereof (A23L33/145 takes precedence) |
| Total patents | 148 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 11 |
| 2016 | 9 |
| 2017 | 17 |
| 2018 | 19 |
| 2019 | 6 |
| 2020 | 20 |
| 2021 | 13 |
| 2022 | 13 |
| 2023 | 18 |
| 2024 | 12 |
| 2025 | 8 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Compositions and methods for improving mitochondrial function
US-2019255124-A1 · Aug 22, 2019 · US
Composition Using Slip-Robo System For Preventing Or Treating Sarcopenia
US-2019133173-A1 · May 9, 2019 · US
Composition for regulating cutaneous pigmentation or skin whitening comprising sdf1
US-2019125835-A1 · May 2, 2019 · US
Agents and methods using thereof for the prevention and treatment of stem cell muscle disorders
US-2018360862-A1 · Dec 20, 2018 · US
Supplementation of milk formulas with microvesicles isolated from milk
US-2018343882-A1 · Dec 6, 2018 · US
Nicotinamide mononucleotide derivative and salt thereof, method for producing same, topical skin preparation, cosmetic and food additive
US-2018334474-A1 · Nov 22, 2018 · US
Composition for preventing or treating atopic dermatitis comprising X-shape DNA structure as active ingredient
US-10125367-B2 · Nov 13, 2018 · US
Method for improving white matter integrity in hyperphenylalaninemia and phenylketonuria patients
US-2018311196-A1 · Nov 1, 2018 · US
Pharmaceutical composition for metabolic disease comprising expression or activity inhibitor of mkrn1 as an active ingredient
US-2018305698-A1 · Oct 25, 2018 · US
Method for improving equilibrioception in healthy individuals and nutritional composition
US-2018280332-A1 · Oct 4, 2018 · US
Method for treating neurotrauma
US-10071072-B2 · Sep 11, 2018 · US
Adiponectin secretion enhancer
US-2018228824-A1 · Aug 16, 2018 · US
Nutritional composition for improving brain function in phenylketonuria
US-10039732-B2 · Aug 7, 2018 · US
Synergistic nutritional compositions and uses thereof
US-10034937-B2 · Jul 31, 2018 · US
Composition containing nad for preventing and treating obesity or impaired glucose tolerance
US-2018207190-A1 · Jul 26, 2018 · US
Variant of d-psicose 3-epimerase and uses thereof
US-2018179510-A1 · Jun 28, 2018 · US
Steviol glucosyltransferases and genes encoding the same
US-10000783-B2 · Jun 19, 2018 · US
Method for improving bladder function
US-2018110794-A1 · Apr 26, 2018 · US
Composition for preventing or treating atopic dermatitis comprising x-shape dna structure as active ingredient
US-2018080029-A1 · Mar 22, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC A23L33/13?
- CPC A23L33/13 is the Cooperative Patent Classification code for “Nucleic acids or derivatives thereof (A23L33/145 takes precedence).”
- How many patents are filed under CPC A23L33/13 (Nucleic acids or derivatives thereof (A23L33/145 takes precedence))?
- Our database includes 148 publications tagged with this CPC code.
- Is patent activity under CPC A23L33/13 growing?
- Publication counts under this code: 12 in 2024 vs 8 in 2025 (latest complete years).